These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16817356)

  • 1. [Postmenopausal osteoporosis].
    Miki T; Tamura A
    Nihon Rinsho; 2006 Jun; Suppl 2():81-6. PubMed ID: 16817356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and treatment of postmenopausal osteoporosis].
    Mizunuma H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():490-4. PubMed ID: 18161154
    [No Abstract]   [Full Text] [Related]  

  • 3. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis: handy tools for detection, helpful tips for treatment.
    Morgan SL; Kitchin B
    J Fam Pract; 2008 May; 57(5):311-20. PubMed ID: 18460296
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic management of osteoprosis and osteopenia.
    Alexander IM
    Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
    [No Abstract]   [Full Text] [Related]  

  • 8. [New bone density conservation agents for osteoporosis under research and development: Minodronic acid].
    Takata S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():417-20. PubMed ID: 18161142
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis.
    Brandi ML
    Curr Med Res Opin; 2010 Nov; 26(11):2553-63. PubMed ID: 20858031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?].
    Thomas T; Reach G; Lespessailles E
    Rev Prat; 2006 Jan; Spec No():3-11. PubMed ID: 16502833
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonates for osteoporosis.
    Favus MJ
    N Engl J Med; 2010 Nov; 363(21):2027-35. PubMed ID: 21083387
    [No Abstract]   [Full Text] [Related]  

  • 12. New ways to manage the old problem of osteoporosis.
    Baran DT
    JAAPA; 1999 Sep; 12(9):42-6, 49-50, 52. PubMed ID: 10728100
    [No Abstract]   [Full Text] [Related]  

  • 13. [Postmenopausal osteoporosis].
    László A
    Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice. Postmenopausal osteoporosis.
    Rosen CJ
    N Engl J Med; 2005 Aug; 353(6):595-603. PubMed ID: 16093468
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of postmenopausal osteoporosis for primary care.
    Miller P; Lukert B; Broy S; Civitelli R; Fleischmann R; Gagel R; Khosla S; Lucas M; Maricic M; Pacifici R; Recker R; Sarran HS; Short B; Short MJ
    Menopause; 1998; 5(2):123-31. PubMed ID: 9689207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of osteoporosis.
    Miller PD
    Adv Intern Med; 1999; 44():175-207. PubMed ID: 9929709
    [No Abstract]   [Full Text] [Related]  

  • 17. ["European Guidance 2008" for the diagnosis and management of postmenopausal osteoporosis--what is new and clinically relevant?].
    Bartl R;
    Dtsch Med Wochenschr; 2009 Jan; 134(3):92-4. PubMed ID: 19142840
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of osteoporotic fractures in post-menopausal women.
    Compston J
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun; 14(2):251-64. PubMed ID: 11035905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates.
    Al-Azzawi F
    Gynecol Endocrinol; 2008 Nov; 24(11):601-9. PubMed ID: 19031214
    [No Abstract]   [Full Text] [Related]  

  • 20. Lasofoxifene: new drug. Osteoporosis: no better than raloxifene.
    Prescrire Int; 2009 Dec; 18(104):247. PubMed ID: 20020572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.